FGF-23 and the Risk of Stroke and Cognitive Decline

Project: Research project

Project Details


This project focuses on studies of disordered mineral metabolism as a risk factor for stroke and other cardiovascular diseases in the Northern Manhattan Study (NOMAS). This is the first large-scale study of disordered mineral metabolism and stroke in a general population without high rates of chronic kidney disease. As an expert in disordered mineral metabolism in chronic kidney disease and the general population, Dr. Wolf will assist the PI in executing all aspects of the award.
Effective start/end date9/6/138/31/16


  • University of Miami (66917H/5R01HL108623-04 // 66917H/5R01HL108623-04)
  • National Heart, Lung, and Blood Institute (66917H/5R01HL108623-04 // 66917H/5R01HL108623-04)


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.